BRIEF-Valeant appoints Paul Herendeen as chief financial officer
Aug 22 (Reuters) - Valeant Pharmaceuticals International Inc :
* Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer
* Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately
* Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc. For two years
* Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.